Latest News about MIRM
Recent news which mentions MIRM
   Uber To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Tuesday
   
  
  
  December 19, 2023
  From Benzinga
 
   Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session
   
  
  
  December 18, 2023
  From Benzinga
 
   11 Analysts Have This to Say About Mirum Pharmaceuticals
   
  November 20, 2023
  Tickers 
   MIRM
  
  
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023
   
  
  
  October 24, 2023
  From Benzinga
 
   7 Small-Cap Stocks That Get the Nod from Wall Street
   
  
  
  October 11, 2023
  From InvestorPlace
 
   Why Shares of Travere Therapeutics Are Slumping Thursday
   
  
  
  September 21, 2023
  From Motley Fool
 
   Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2023
   
  
  
  September 20, 2023
  From Benzinga
 
   Around $4M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
   
  
  
  September 06, 2023
  From Benzinga
 
   Raymond James Maintains Strong Buy Rating for Mirum Pharmaceuticals: Here's What You Need To Know
   
  July 18, 2023
  Tickers 
   MIRM
  
  
  From Benzinga
 From Benzinga
 
   Travere Therapeutics Offloads Bile Acid Product Portfolio: Says Divestment Strengthens Financial Foundation
   
  
  
  July 17, 2023
  From Benzinga
 
   Why Panbela Therapeutics Shares Are Trading Higher By Around 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
   
  
  
  April 12, 2023
  From Benzinga
 
   American Airlines, Cutera, Mirum Pharmaceuticals And Other Big Stocks Moving Lower On Wednesday
   
  
  
  April 12, 2023
  From Benzinga
 
   Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
   
  
  
  March 11, 2023
  From Benzinga
 
   Earnings Scheduled For March 8, 2023
   
  
  
  March 08, 2023
  From Benzinga
 From Benzinga
 
   Mirum Pharmaceuticals's Return On Capital Employed Insights
   
  December 14, 2022
  Tickers 
   MIRM
  
  
  From Benzinga
 
   Europe Approves Mirum Pharma's Drug For Rare Genetic Liver Disease
   
  December 13, 2022
  Tickers 
   MIRM
  
  
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
